Samsung Biologics Co Ltd
KRX:207940
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Samsung Biologics Co Ltd
KRX:207940
|
KR |
|
Credit Suisse Group AG
F:CSX1
|
CH |
|
Paychex Inc
NASDAQ:PAYX
|
US |
|
H
|
Hancock Whitney Corp
F:HH1
|
US |
|
Fraport AG Frankfurt Airport Services Worldwide
OTC:FPRUF
|
DE |
|
K
|
Kawasaki Heavy Industries Ltd
XBER:KHE
|
JP |
|
I
|
Intesa Sanpaolo SpA
BMV:ISPN
|
IT |
|
Paramount Global
NASDAQ:PSKY
|
US |
|
Nippon Sanso Holdings Corp
OTC:TYNPF
|
JP |
|
H
|
Halliburton Co
XBER:HAL
|
US |
|
C
|
Corning Inc
SWB:GLW
|
US |
|
E
|
Eli Lilly and Co
BMV:LLY
|
US |
Shareholder Yield
Current shareholder yield for Samsung Biologics Co Ltd is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
Price
Samsung Biologics Co Ltd
| Average Annual Return |
N/A
|
| Standard Deviation of Annual Returns |
N/A
|
| Max Drawdown |
N/A
|
| Market Capitalization | 46.3T KRW |
| Shares Outstanding | 46 290 000 |
| Percentage of Shares Shorted |
N/A
|
